Develops biomarkers for detecting Alzheimer's disease pathology before clinical symptoms emerge. Combines MRI, PET, sensory measures, genetics, and assessments of vascular, medication, diet, and exercise factors to understand how comorbidities and lifestyle influence dementia risk and biomarker profiles.